These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31080846)

  • 1. Production of CRISPR/Cas9-Mediated Self-Cleaving Helper-Dependent Adenoviruses.
    Palmer DJ; Turner DL; Ng P
    Mol Ther Methods Clin Dev; 2019 Jun; 13():432-439. PubMed ID: 31080846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAd5/35
    Li C; Psatha N; Gil S; Wang H; Papayannopoulou T; Lieber A
    Mol Ther Methods Clin Dev; 2018 Jun; 9():390-401. PubMed ID: 30038942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single "All-in-One" Helper-Dependent Adenovirus to Deliver Donor DNA and CRISPR/Cas9 for Efficient Homology-Directed Repair.
    Palmer DJ; Turner DL; Ng P
    Mol Ther Methods Clin Dev; 2020 Jun; 17():441-447. PubMed ID: 32154329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
    Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
    Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helper virus-mediated downregulation of transgene expression permits production of recalcitrant helper-dependent adenoviral vector.
    Palmer DJ; Grove NC; Ng P
    Mol Ther Methods Clin Dev; 2016; 3():16039. PubMed ID: 27331077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.
    Huo W; Zhao G; Yin J; Ouyang X; Wang Y; Yang C; Wang B; Dong P; Wang Z; Watari H; Chaum E; Pfeffer LM; Yue J
    J Cancer; 2017; 8(1):57-64. PubMed ID: 28123598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
    Kurata JS; Lin RJ
    RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing.
    Ortinski PI; O'Donovan B; Dong X; Kantor B
    Mol Ther Methods Clin Dev; 2017 Jun; 5():153-164. PubMed ID: 28497073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and modular CRISPR-Cas9 vector system for
    Mallett DR; Chang M; Cheng X; Bezanilla M
    Plant Direct; 2019 Sep; 3(9):e00168. PubMed ID: 31523744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
    Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
    Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient genome editing.
    Degreif D; Kremenovic M; Geiger T; Bertl A
    J Biol Methods; 2018; 5(3):e98. PubMed ID: 31453248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
    Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
    FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
    Ophinni Y; Inoue M; Kotaki T; Kameoka M
    Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
    Muramoto T; Iriki H; Watanabe J; Kawata T
    Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.
    Mao Y; Yang X; Zhou Y; Zhang Z; Botella JR; Zhu JK
    Genome Biol; 2018 Sep; 19(1):149. PubMed ID: 30266091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation.
    Shen CC; Hsu MN; Chang CW; Lin MW; Hwu JR; Tu Y; Hu YC
    Nucleic Acids Res; 2019 Feb; 47(3):e13. PubMed ID: 30462300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.